Model Based Support to Biosimilarity Assessment Planning – A Case Study of Pegfilgrastim

PAGE 28 (2019) Abstr 9166.
Brekkan A, Lopez-Lazaro L, Plan EL, Acharya C, Yngman G, Nyberg J, Hooker AC, Kankanwadi S, Karlsson MO.
ConferenceHematologyPharmacometricsSpecial considerations

Pharmetheus Affiliates

Portrait-of-Ari-Brekkan-Pharmetheus
Senior Consultant, R&D Scientist

Ari Brekkan

See bio
Portrait-of-Elodie-Plan_Pharmetheus-1
Chief Business Development Officer & Deputy CEO

Elodie Plan

See bio
Portrait-of-Chayan-Acharya_Pharmetheus
Senior Consultant

Chayan Acharya

See bio
Portrait-of-Joakim-Nyberg-Pharmetheus
Chief Technology Officer

Joakim Nyberg

See bio
Portrait-of-Andrew-Hooker_Pharmetheus
Scientific Advisor

Andrew Hooker

See bio
Portrait-of-Mats-Karlsson_Pharmetheus
Scientific Advisor & Board Member

Mats Karlsson

See bio